肿瘤球形度是否为肺癌患者重要预后因素?
研究从457例肺癌患者放疗计划CT中提取大体肿瘤体积(GTV)球形度,分析其与总生存(OS)的关系。单因素分析中球形度与OS强相关(p<0.001,HR=0.13,95%CI 0.04-0.41),但多因素分析中不显著(p=0.826,HR=0.83,95%CI 0.16-4.31),加入球形度未改善临床模型性能;N0亚组(290例)单因素(p=0.072)和多因素(p=0.920)均无显著关系。结论认为球形度与临床预后因素明显相关,且受GTV是否包含淋巴结影响。
要点
- GTV球形度与肿瘤体积、平均肺剂量、N分期和T分期相关。
- 单因素分析球形度与OS强相关,但多因素分析不显著。
- N0亚组中球形度与OS无显著关系。
核心结论
- 球形度与临床预后因素明显相关,而这些因素在影像组学研究中常未被考虑。
- 球形度也受GTV轮廓内是否存在淋巴结受累的影响。
研究设计与样本
- 从457例肺癌患者的单次GTV勾画中提取球形度。
- 通过相关分析和多因素Cox回归评估GTV球形度的预后价值。
- 对290例N0期患者进行亚组分析以确定原发肿瘤球形度的预后价值。
主要发现
- 球形度与肿瘤体积、平均肺剂量、N分期和T分期相关。
- 单因素分析中球形度与OS强相关(p < 0.001,HR(95%CI)= 0.13(0.04-0.41))。
- 多因素分析中该关联不显著(p = 0.826,HR(95%CI)= 0.83(0.16-4.31)),且将球形度加入临床模型未改善模型性能。
- N0亚组单因素分析(p = 0.072)和多因素分析(p = 0.920)均未检测到球形度与OS的显著关系。
临床怎么用
- 在放射治疗科评估肺癌预后时,不应仅依赖GTV球形度,需结合临床预后因素综合判断。
- 勾画GTV时需注意是否包含淋巴结,因其影响球形度的预后价值。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND PURPOSE: Quantitative tumour shape features extracted from radiotherapy planning scans have shown potential as prognostic markers. In this study, we investigated if sphericity of the gross tumour volume (GTV) on planning computed tomography (CT) is an independent predictor of overall survival (OS) in lung cancer patients treated with standard radiotherapy. In the analysis, we considered whether tumour sphericity is correlated with clinical prognostic factors or influenced by the inclusion of lymph nodes in the GTV. MATERIALS AND METHODS: Sphericity of single GTV delineation was extracted for 457 lung cancer patients. Relationships between sphericity, and common patient and tumour characteristics were investigated via correlation analysis and multivariate Cox regression to assess prognostic value of GTV sphericity. A subset analysis was performed for 290 nodal stage N0 patients to determine prognostic value of primary tumour sphericity. RESULTS: Sphericity is correlated with clinical variables: tumour volume, mean lung dose, N stage, and T stage. Sphericity is strongly associated with OS (p < 0.001, hazard ratio (HR) (95% confidence interval (CI)) = 0.13 (0.04-0.41)) in univariate analysis. However, this association did not remain significant in multivariate analysis (p = 0.826, HR (95% CI) = 0.83 (0.16-4.31), and inclusion of sphericity to a clinical model did not improve model performance. In addition, no significant relationship between sphericity and OS was detected in univariate (p = 0.072) or multivariate (p = 0.920) analysis of N0 subset. CONCLUSION: Sphericity correlates clearly with clinical prognostic factors, which are often unaccounted for in radiomic studies. Sphericity is also influenced by the presence of nodal involvement within the GTV contour.
引用
- Davey A, van Herk M, Faivre-Finn C, et al. Is tumour sphericity an important prognostic factor in patients with lung cancer? Radiother Oncol. 2019. PMID: 31472998. doi:10.1016/j.radonc.2019.08.003
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。